Pharmaceutical Business review

US court rules in favour of Affymetrix

Affymetrix executive vice president, general counsel and secretary Rick Runkel said they are pleased that the Federal Circuit has affirmed the District Court’s prior rulings that Affymetrix does not infringe the asserted patents and dismissing Illumina’s lawsuits.

"we are committed to conducting our business with the utmost integrity and believe the ruling of both the District Court and the Court of Appeals underscore this commitment," Runkel said.